Inhibiting cancer growth by targeting the TNFR2 oncogene with TNFR2 antagonistic antibodies

被引：0
|
作者：
Torrey, Heather
Butterworth, John
Mera, Toshiyuki
Okubo, Yoshiaki
Wang, Limei
Baum, Danielle
Defusco, Audrey
Plager, Sara
Warden, Sarah
Huang, Daniel
Vanamee, Eva
Foster, Rosemary
Faustman, Denise L.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2136
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2136
引用
收藏
页数：2
相关论文
共 50 条
  • [31] TNFR2 activates JNK but not MAPK pathways
    Jean-Noel Gouze
    Arthritis Research & Therapy, 4 (1)
  • [32] TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages
    Wajant, Harald
    Siegmund, Daniela
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2019, 7
  • [33] Biomechanical strain regulates TNFR2 but not TNFR1 in TMJ cells
    Deschner, James
    Rath-Deschner, Birgit
    Wypasek, Ewa
    Anghelina, Mirela
    Sjostrom, Danen
    Agarwal, Sudha
    JOURNAL OF BIOMECHANICS, 2007, 40 (07) : 1541 - 1549
  • [34] Activation of TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis
    Daniela Siegmund
    Juliane Kums
    Martin Ehrenschwender
    Harald Wajant
    Cell Death & Disease, 2016, 7 : e2375 - e2375
  • [35] Towards understanding the role of nanomedicine in targeting TNFR2 in rheumatoid arthritis
    Lambuk, Fatmawati
    Nordin, Nor Asyikin
    Mussa, Ali
    Lambuk, Lidawani
    Ahmad, Suhana
    Hassan, Rosline
    Kadir, Ramlah
    Mohamud, Rohimah
    Yahya, Nurul Khaiza
    IMMUNOLOGY, 2024, 173 (04) : 622 - 633
  • [36] Activation of TNFR2 sensitizes macrophages for TNFR1-mediated necroptosis
    Siegmund, Daniela
    Kums, Juliane
    Ehrenschwender, Martin
    Wajant, Harald
    CELL DEATH & DISEASE, 2016, 7 : e2375 - e2375
  • [37] Targeting TNFR2 for cancer immunotherapy: Ligand blocking depletors versus receptor agonists
    Martensson, Linda
    Cleary, Kirstie
    Semmrich, Monika
    Kovacek, Mathilda
    Holmkvist, Petra
    Svensson, Caroline
    Demiri, Mimoza
    Blidberg, Therese
    Thornberg, Ulla-Carin
    Pitic, Vincentiu
    Dadas, Osman
    Lim, Sean H.
    Beers, Stephen A.
    Cragg, Mark S.
    Frendeus, Bjorn
    Teige, Ingrid
    CANCER RESEARCH, 2020, 80 (16)
  • [38] Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis
    Verwoerd, A.
    Hijdra, D.
    Vorselaars, A. D. M.
    Crommelin, H. A.
    van Moorsel, C. H. M.
    Grutters, J. C.
    Claessen, A. M. E.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 185 (02): : 263 - 270
  • [39] Targeting TNFR2 to overcome acquired adaptive resistance to immune checkpoint blockade
    Mayer, Lena Sophie
    Orlowski, Robert J.
    Giles, Josephine
    Benci, Joseph L.
    Ellis, Gavin
    Deng, Guoping
    Attanasio, John
    Chen, Zeyu
    Bengsch, Bertram
    Kahn, Omar
    Manne, Sasikanth
    Herati, Ramin S.
    Ngiow, Shin
    George, Sangeeth M.
    Faustman, Denise L.
    Gilliland, Gary
    Mick, Rosemarie
    Xu, Wei
    McGettigan, Suzanne
    Xu, Xiaowei
    Amaravadi, Ravi K.
    Karakousis, Giorgos C.
    Schuchter, Lynn M.
    Mitchell, Tara C.
    Riley, James L.
    Huang, Alexander C.
    Minn, Andy
    Tomov, Vesselin
    Wherry, E. John
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [40] Harnessing the Expression of TNFR2 on Tregs to Prevent Agvhd
    Vargas, Juan Gamboa
    Kanzler, Carla
    Scheller, Lukas
    Kreckel, Jennifer
    Shaikh, Haroon
    Lang, Isabell
    Medler, Juliane
    Anany, Mohamed
    Steinfatt, Tim
    Hartweg, Julia
    Haack, Stefanie
    Holler, Ernst
    Buettner-Herold, Maike
    Gaviria, Paula Tabares
    Wajant, Harald
    Beilhack, Andreas
    Einsele, Hermann
    BLOOD, 2022, 140 : 4465 - 4466
12345